|
|
Inverness Medical Innovations, Inc. (NYSE: IMA) is at the
forefront of the convergence between medical diagnostic
testing and health management. IMA is a major global
developer, manufacturer and marketer of advanced, pioneering
professional and consumer
medical diagnostic products, as well as a leader in specialized
health management services including wellness, disease
management, oncology and women and children's health.
In its role as a leading supplier of
consumer pregnancy,
fertility/ovulation tests and
rapid point-of-care diagnostics, IMA is committed to advancing
health through a continuing flow of innovative new products brought
about by our strong investment in R&D and intellectual
property. Our latest areas of focus in diagnostics are the
application of patented technologies to our consumer and
professional diagnostics products, principally to the fields of
infectious disease,
cardiology,
oncology,
drugs of abuse and
women's health.
Our health management programs provide interventions designed to
cover the entire lifespan from pre-cradle (maternity programs) to
end-of-life care (complex care programs). This continuum of
services addresses the healthcare needs of health plan and employer
populations, while at the same time enabling healthcare providers
to improve clinical outcomes and lower costs. Beyond the
services offered today, we plan to continue expanding and building
the broadest, most fully-integrated and patient-centered portfolio
of health management services in our industry.
With major research & development and operational centers in
the
US,
UK,
Germany and
Israel, and manufacturing sites in the
UK,
China,
Japan and the
US, IMA is truly global in scope.
Inverness Medical Innovations brings together the most complete
form of care with the convergence of advances in medical
diagnostics and personal health support. The benefits are better
health, consumers gaining greater control of their own health and
lower costs.
Inverness Medical Innovations transforming
healthcare by empowering people.
|
|